Enoxaparin: Difference between revisions
Neil.m.young (talk | contribs) (Text replacement - "==Sources==" to "==References==") |
|||
| Line 47: | Line 47: | ||
*[[Anticoagulant reversal for life-threatening bleeds]] | *[[Anticoagulant reversal for life-threatening bleeds]] | ||
== | ==References== | ||
<references/> | <references/> | ||
[[Category:Pharmacology]] | [[Category:Pharmacology]] | ||
[[Category:Heme/Onc]] | [[Category:Heme/Onc]] | ||
Revision as of 12:23, 26 June 2016
General
- Type: Low molecular weight heparin
- Dosage Forms:
- Common Trade Names: Lovenox
Adult Dosing
Pediatric Dosing
Special Populations
- Pregnancy Rating:
- Lactation:
- Renal Dosing
- Renal impairment (Cr clearance <30)
- Use 50% of usual dose or use UFH instead
- Adult
- Pediatric
- Renal impairment (Cr clearance <30)
- Hepatic Dosing
- Adult
- Pediatric
- Obesity
- Weight-based dosing safe up to 190kg (no data available thereafter)
Indications
Contraindications
- Allergy to class/drug
Adverse Reactions
- Bleeding
- Pruritus
- Local skin reaction
Pharmacology
- Half-life:
- Metabolism:
- Excretion:
- Mechanism of Action: